Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study
在BRCA1/2局部复发/转移性乳腺癌患者中，维利帕尼联合替莫唑胺或卡铂/紫杉醇与安慰剂联合卡铂/紫杉醇的疗效比较：一项随机II期研究
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdx505
Han, H S; Diéras, V; Robson, M; Palácová, M; Marcom, P K; Jager, A; Bondarenko, I; Citrin, D; Campone, M; Telli, M L; Domchek, S M; Friedlander, M; Kaufman, B; Garber, J E; Shparyk, Y; Chmielowska, E; Jakobsen, E H; Kaklamani, V; Gradishar, W; Ratajczak, C K; Nickner, C; Qin, Q; Qian, J; Shepherd, S P; Isakoff, S J; Puhalla, S
